Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Baylor College of Medicine (1)

Centre Jean Perrin (1)

Nuvation Bio Inc. (1)

Collaborator

Cook Children's Medical Center (1)

ECS Progastrin (1)

M.D. Anderson Cancer Center (1)

The University of Texas Health Science Center at San Antonio (1)

University of Oklahoma (1)

University of Texas, Southwestern Medical Center at Dallas (1)

Intervention

bevacizumab (1)

blood sample (1)

nuv-422 (1)

radiation therapy (1)

valproic acid (1)

Study Documents

Intervention Type

drug (2)

biological (1)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

glial cell tumors

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated

Glioma
+23 more

NUV-422

Tucson, Arizona
+11 more

Sep 30, 2022

hPG80 asBlood Biomarker for High-grade Glial Tumors

Recruiting

Glial Cell Tumors

Blood sample

Clermont-Ferrand, France

Centre Jean PERRIN

Feb 14, 2022

Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

Completed

Has Results

Glial Cell Tumors
+7 more

Valproic acid
+2 more

Oklahoma City, Oklahoma
+5 more

Jun 30, 2021